Skip to main content

8 Result(s)

within A. Fabbri Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study

    Immunosuppressive dosing of corticosteroids at the start of treatment impairs immune checkpoint inhibitor (ICI) efficacy in advanced non-small cell lung cancer (NSCLC). Previous cumulative dose and intake moda...

    F. Nelli, A. Virtuoso, J. R. Giron Berrios… in Cancer Chemotherapy and Pharmacology (2022)

  2. No Access

    Article

    First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study

    The role of cisplatin in the first-line treatment for elderly advanced non-small-cell lung cancer is not completely defined. We previously reported in this subset of patients an interesting efficacy and tolera...

    C. Tibaldi, A. Camerini, A. D’Incecco… in Journal of Cancer Research and Clinical On… (2012)

  3. No Access

    Article

    Reply to ‘Rituximab activity in CD20-positive multiple myeloma’

    A Gozzetti, A Fabbri, S Lazzi, M Bocchia, F Lauria in Leukemia (2008)

  4. Article

    Open Access

    First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study

    This multicenter phase II study evaluated, in chemonaive patients with stage IIIB–IV NSCLC, age ⩾70 and with a performance status 0–2, the activity, efficacy and tolerability of planned sequential administrati...

    C Tibaldi, E Vasile, A Antonuzzo, R Di Marsico, A Fabbri… in British Journal of Cancer (2008)

    Download PDF (175 KB) View Article

  5. No Access

    Article

    Reply to Rituximab activity in CD20 positive multiple myeloma

    A Gozzetti, A Fabbri, S Lazzi, M Bocchia, F Lauria in Leukemia (2007)

  6. Article

    Open Access

    Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study

    The aim of this study was to evaluate feasibility and toxicity of escalating doses of epirubicin and paclitaxel plus fixed dose of etoposide and to define the activity of the triplet in extensive disease small...

    C Tibaldi, T Prochilo, F Russo, M C Pennucci, A Del Freo… in British Journal of Cancer (2006)

    Download PDF (101 KB) View Article

  7. Article

    Open Access

    SYT-SSX fusion genes and prognosis in synovial sarcoma

    A case series of 64 synovial sarcomas was characterized for the SYT-SSX fusion transcripts and statistically analysed in order to correlate molecular data with prognosis and morphology. SYT-SSX1 fusion transcr...

    A Mezzelani, L Mariani, E Tamborini, V Agus, C Riva… in British Journal of Cancer (2001)

    Download PDF (203 KB)

  8. No Access

    Article

    Involvement of chromosome 6 in endometrial cancer

    Cytogenetic investigation was performed on direct preparations of 15 endometrial cancers showing different histotypes. Clonal abnormalities were found in 11 out of 13 analysable cases. The modal chromosome num...

    MG Tibiletti, B Bernasconi, M Taborelli, D Furlan, A Fabbri… in British Journal of Cancer (1997)